We Will Participate in “DEEPTECH STARTUP PITCH in TOKYO” Hosted by Tokushima Prefecture

Feb 13
1 min read

Our company will participate in the “DEEPTECH STARTUP PITCH in TOKYO,” which will be held in Tokyo on Thursday, March 12, 2026.

■ Event Overview

“DEEPTECH STARTUP PITCH in TOKYO” is a pitch event where Tokushima Prefecture’s leading deep-tech startups present their technologies and future potential to investors and organizations seeking new investment and collaboration opportunities.

This event offers a firsthand look at the forefront of innovation emerging from Tokushima, as local startups with global ambitions showcase deep-tech solutions aimed at addressing societal challenges.

Event Name: DEEPTECH STARTUP PITCH in TOKYO

Date & Time: Thursday, March 12, 2026, 3:00 PM – 6:00 PM

Venue: TOKYO VENTURE CAPITAL HUB

(Azabudai Hills Garden Plaza B, 5F, 5-9-1 Toranomon, Minato-ku, Tokyo)

Event Details: https://www.pref.tokushima.lg.jp/file/attachment/1034251.pdf

■ Contact for Inquiries Regarding This Event

info@southwood.co.jp

Comments

We Will Participate in “DEEPTECH STARTUP PITCH in TOKYO” Hosted by Tokushima Prefecture

Our company will participate in the “DEEPTECH STARTUP PITCH in TOKYO,” which will be held in Tokyo on Thursday, March 12, 2026. ■ Event Overview “DEEPTECH STARTUP PITCH in TOKYO” is a pitch event where Tokushima Prefecture’s leading deep-tech startups present their technologies and future potential to investors and organizations seeking new investment and collaboration opportunities. This event offers a firsthand look at the forefront of innovation emerging from Tokushima, as

Feb 13

A Study Session Using the “Butterfly iQ3™” Was Held at Okayama University

Southwood Co., Ltd. (Headquarters: Tokushima City, Tokushima Prefecture; President: Kenya Kusunose), an authorized distributor, hosted a study session using the portable ultrasound imaging device “Butterfly iQ3™,” manufactured by Butterfly Network, Inc. (USA). The session, organized by the Regional Medical Personnel Development Program, was held at Okayama University on January 17, 2026. Physicians, residents, and students involved in regional healthcare participated in hands

Feb 10

We have issued a self-declaration of conformity in accordance with the international standard for post-editing, ISO 18587:2017.

Southwood Co., Ltd. (Headquarters: Tokushima City, Tokushima Prefecture; President: Kenya Kusunose) declared self-conformity with the international standard for post-editing (the process of human correction of machine translation output), ISO 18587:2017, on January 22, 2026. This declaration was implemented based on the Guidelines for Issuing a Supplier Declaration of Conformity to ISO 18587 established by the Asia-Pacific Association for Machine Translation (AAMT). ◼︎ ◼︎For

Jan 26

Type II Medical Device Manufacturing and Sales Business license from the Tokyo Metropolitan Government as of November 13, 2025.

Southwood Inc. otained a “Type II Medical Device Manufacturing and Sales License” from the Tokyo Metropolitan Government on November 13, 2025. This enables us to manufacture and sell program-based medical devices, including medical AI, up to Class II. ■License Information Manufacturing Facility Name：Southwood Co., Ltd. Manufacturing Facility Address：1 Bancho, Chiyoda-ku, Tokyo Registration Number：13B2X10646 ■Contact for Inquiries Regarding This Matter info@southwood.co.jp

Dec 5, 2025

Southwood to Exhibit and Pitch at the Japan Healthcare Venture Summit 2025

Southwood Inc. is pleased to announce that we will be exhibiting at the Japan Healthcare Venture Summit 2025 (JHVS 2025), hosted by the...

Oct 1, 2025

“Butterfly iQ3” Portable Ultrasound Device by U.S. Butterfly Network Receives MedicalDevice Certification in Japan

— Southwood Inc. to Begin Sales from September 1, 2025 — Southwood Inc. (Headquarters: Tokushima City, Tokushima Prefecture; CEO: Kenya...

Aug 20, 2025